Suven Pharmaceuticals Share Price
NSE: COHANCE|BSE: 543064|Pharmaceuticals₹1,019.80
+₹6.85 (0.68%) As on 09 Sep, 2025 | 15:56 ISTSuven Pharmaceuticals Stock Performance
Market cap  ₹38,752 Crs | Open ₹991.50 | Prev. Close ₹1,012.95 |
Circuit range ₹1,215.50 - ₹810.40 | Day range ₹985.35 - ₹1,027.00 | Year range ₹856.30 - ₹1,360.00 |
Volume 5,15,762 | Avg. traded ₹1,008.41 | Revenue (12m) ₹1,516 Crs |
About Suven Pharmaceuticals
Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, is an India-based technology-driven contract development and manufacturing organization (CDMO), providing integrated solutions in custom synthesis, process research and development (R&D), and manufacturing. The Company’s business units include pharmaceutical CDMO, specialty chemical CDMO, and active pharmaceutical ingredient (API) (including formulations). Its integrated CDMO model enables comprehensive molecule development and life cycle management for both pharmaceutical and specialty chemical partners. Its custom synthesis services include design and synthesis, synthesis of complex molecules, synthesis of reference standards, synthesis of impurities and metabolites, scale-up of existing synthetic routes, and process optimization and backward integration. Its process research services include route scouting, process development, process safety evaluation, analytical method development, and regulatory support.
As of last trading day, Suven Pharmaceuticals opened at ₹991.50 and last traded at ₹1,019.80, showing a rise of 6.85 points (0.68%) compared to the previous close of ₹1,012.95. During the session, the stock touched a high of ₹1,027.00 and a low of ₹985.35. The company's market capitalization now stands at ₹38,752 Crs, with a P/E ratio of 108.3 and a dividend yield of 0.00%.
10 September 2025 – Suven Pharmaceuticals Share Price Update
As of last trading day, Suven Pharmaceuticals opened at ₹991.50 and last traded at ₹1,019.80, showing a rise of 6.85 points (0.68%) compared to the previous close of ₹1,012.95. During the session, the stock touched a high of ₹1,027.00 and a low of ₹985.35. The company's market capitalization now stands at ₹38,752 Crs, with a P/E ratio of 108.3 and a dividend yield of 0.00%.Suven Pharmaceuticals Share Price Chart
₹1,019.80+₹6.85 (0.68%)
Please wait...
Suven Pharmaceuticals Key Indicators
P/E ratio 108.32 | P/B ratio 17.4 | ROE 12.51% |
ROCE 15.94% | Dividend yield -- | Debt/Equity ratio 0.04 |
EPS 12.89 |
Investment Checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst Ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 6 experts in the last 7 days
Suven Pharmaceuticals Financial Ratios
Operating profit margin38.09% | Net profit margin24.85% |
ROE12.51% | ROA11.25% |
ROCE15.94% |
Quick ratio2.6 | Current ratio2.24 |
Interest coverage44.92 | Asset turnover1.05 |
Debt to Equity0.04 |
P/E ratio108.32 | P/B ratio17.4 |
EV / EBITDA71.06 | |
Dividend yield0% |
Suven Pharmaceuticals Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-25 | ₹2,677.71 | ₹642.63 | ₹484.24 |
Mar-24 | ₹1,113.26 | ₹405.67 | ₹300.28 |
Mar-23 | ₹1,386.69 | ₹559.73 | ₹411.29 |
Mar-22 | ₹1,412.60 | ₹667.59 | ₹453.80 |
Suven Pharmaceuticals Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-25 | ₹-255.3 | ||
Mar-24 | ₹-362.35 | ₹-39.99 | |
Mar-23 | ₹-195.01 | ₹-241.95 | |
Mar-22 | ₹-136.14 | ₹-156.48 |
Suven Pharmaceuticals Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-25 | ₹3,031.75 | ₹3,031.75 |
Mar-24 | ₹2,254.09 | ₹2,254.09 |
Mar-23 | ₹1,965.74 | ₹1,965.74 |
Mar-22 | ₹1,829.59 | ₹1,829.59 |
Suven Pharmaceuticals Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
25-Aug-25 | ₹910.05 | ₹898.25 | |
22-Aug-25 | ₹892.00 | ₹884.70 | -1.49% |
21-Aug-25 | ₹885.00 | ₹898.05 | |
20-Aug-25 | ₹920.00 | ₹894.75 | -2.79% |
19-Aug-25 | ₹911.45 | ₹920.40 | |
18-Aug-25 | ₹919.00 | ₹897.35 | -1.81% |
14-Aug-25 | ₹970.00 | ₹913.85 | -7.32% |
13-Aug-25 | ₹969.00 | ₹986.05 |
Stocks Similar to Suven Pharmaceuticals
Stock Name | Price | Change % |
|---|---|---|
| Alembic Pharma | ₹937.75 | -₹9.55 (-1.01%) |
| Eris Lifesciences | ₹1,705.00 | -₹6.50 (-0.38%) |
| Glenmark Pharma | ₹2,116.30 | +₹64.40 (3.14%) |
| Granules India | ₹525.10 | +₹5.85 (1.13%) |
| Jubilant Ingrevia | ₹713.00 | -₹4.70 (-0.65%) |
| Jubilant Pharmova | ₹1,109.60 | +₹3.60 (0.33%) |
| Medplus Health | ₹831.55 | -₹3.30 (-0.4%) |
| Natco Pharma | ₹841.25 | -₹4.85 (-0.57%) |
| Procter & Gamble Health | ₹6,500.00 | -₹28.00 (-0.43%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| HDFC Bank Share Price | ₹965.15 | -₹0.85 (-0.09%) |
| Indus Towers Share Price | ₹346.90 | +₹2.80 (0.81%) |
| ITC Share Price | ₹410.05 | +₹2.50 (0.61%) |
| JIO FIN SERVICES LTD Share Price | ₹307.95 | -₹3.15 (-1.01%) |
| KFin Technologies Share Price | ₹1,099.40 | +₹0.50 (0.05%) |
| MCX Share Price | ₹7,611.50 | -₹20.00 (-0.26%) |
| NIP ETF Liquid Bees Share Price | ₹999.99 | +0.00 (0.00%) |
| Paytm Share Price | ₹1,219.10 | -₹33.90 (-2.71%) |
| Tata Motors Share Price | ₹715.55 | -₹3.95 (-0.55%) |
| Tata Power Share Price | ₹384.65 | +₹1.40 (0.37%) |
Suven Pharmaceuticals News
Moneycontrol
Cohance Life Standalone March 2025 Net Sales at Rs 330.17 crore
Moneycontrol
Cohance Life Consolidated March 2025 Net Sales at Rs 402.02 crore
Upstox
Bulls make a comeback: SENSEX zooms over 1,600 pts, NIFTY50 tops 22,650; check top buzzing stocks of the day
CNBC
Goldman Sachs sees up to 28% upside in two 'consensus buy' pharma stocks
CNBC Television
Goldman Sachs sees up to 28% upside in two 'consensus buy' pharma stocks
Moneycontrol
Buy Suven Pharmaceuticals; target of Rs 1400: ICICI Securities
Suven Pharmaceuticals Share Price FAQs
What is the share price of Suven Pharmaceuticals today?
Suven Pharmaceuticals share price is ₹ 1,019.80 as on Sep, 2025 | 15:56 IST.
What are the high & low stock price of Suven Pharmaceuticals today?
Suven Pharmaceuticals stock price hit a high of ₹ 1,027.00 and low of ₹ 985.35 as on Sep, 2025 | 15:56 IST.
What is the market cap of Suven Pharmaceuticals?
The market cap of Suven Pharmaceuticals is ₹ 38,752.14 Crores as on Sep, 2025 | 15:56 IST.
What are the the 52-week high and low share prices of Suven Pharmaceuticals stock on the NSE?
52-week high stock Price of Suven Pharmaceuticals is ₹ 1,360.00 and Low Price is ₹ 856.30 as on Sep, 2025 | 15:56 IST.
What are the stock symbols of Suven Pharmaceuticals?
The stock symbol of Suven Pharmaceuticals is NSE: COHANCE on the NSE, BSE: 543064 on the BSE, and the ISIN is INE03QK01018.
Can I buy Suven Pharmaceuticals shares on Holidays?
No, shares of Suven Pharmaceuticals or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Suven Pharmaceuticals shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
How to buy Suven Pharmaceuticals shares?
To buy Suven Pharmaceuticals shares,open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order
What is the PE and PB ratio of Suven Pharmaceuticals?
The PE and PB ratio of Suven Pharmaceuticals is 108.32 and 17.4 respectively, as on Sep, 2025 | 15:56 IST.
What are the returns on Suven Pharmaceuticals shares?
The historical returns for Suven Pharmaceuticals shares are -15.6 for 1 year, 106.07 for 3 year and 200.89 for 5 year.